GILD

Gilead Sciences, Inc. Competitors

$55.81
*  
0.33
  negative  
0.59%
Get GILD Alerts
*Delayed - data as of May 24, 2013 
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 

Symbol List Views

Stock Details

CHARTS

COMPANY NEWS

STOCK ANALYSIS

FUNDAMENTALS

HOLDINGS

 Save stocks for next time
 | Sponsored

Competitor Industry: Biotechnology: Biological Products (No Diagnostic Substances)

Gilead Sciences, Inc.
CompanyName
Symbol : Market
LastSale NetChange Volume Today's High/ Low 52 Weeks High/ Low P/ERatio Market Cap
Vical Incorporated
VICL: NASDAQ-GS
$ 3.50 -0.08   455,394 $ 3.61
$ 3.49
$ 4.74
$ 2.61
NE 301,868,000
TrovaGene, Inc.
TROVW: NASDAQ-CM
$ 4.18 0.08   650 $ 4.223
$ 4.18
$ 4.44
$ .2001
NE 4,807,000
TrovaGene, Inc.
TROVU: NASDAQ-CM
$ 16.75 unch n/a
n/a
$ 21.30
$ 4.56
NE 19,262,500
TrovaGene, Inc.
TROV: NASDAQ-CM
$ 6.89 -0.06   92,488 $ 7.10
$ 6.71
$ 8.96
$ 2.09
NE 107,594,240
Techne Corporation
TECH: NASDAQ-GS
$ 66.64 -0.26   106,299 $ 66.98
$ 66.16
$ 76.02
$ 62.55
21.99 2,455,150,880
StemCells, Inc.
STEM: NASDAQ-CM
$ 1.83 -0.05   358,804 $ 1.90
$ 1.82
$ 2.67
$ .59
NE 68,515,200
Sangamo BioSciences, Inc.
SGMO: NASDAQ-GS
$ 7.98 0.05   468,370 $ 8.18
$ 7.77
$ 11.24
$ 4.04
NE 425,756,940
Seattle Genetics, Inc.
SGEN: NASDAQ-GS
$ 34.95 -0.40   545,358 $ 35.40
$ 34.57
$ 39
$ 19.03
NE 4,209,308,100
Repros Therapeutics Inc.
RPRXZ: NASDAQ-CM
$ 15.729 unch n/a
n/a
$ 37.68
$ 8
NE 13,464,024
Repros Therapeutics Inc.
RPRXW: NASDAQ-CM
$ 14.72 unch n/a
n/a
$ 39.99
$ 11.23
NE 12,909,440
Repros Therapeutics Inc.
RPRX: NASDAQ-CM
$ 16.50 0.68   358,039 $ 16.87
$ 15.73
$ 20.78
$ 7.60
NE 282,414,000
Repligen Corporation
RGEN: NASDAQ-GS
$ 8.48 -0.02   114,981 $ 8.5699
$ 8.42
$ 9.65
$ 3.72
17.67 263,829,760
Qiagen N.V.
QGEN: NASDAQ-GS
$ 18.98 0.05   515,731 $ 19.02
$ 18.78
$ 22.20
$ 15.66
37.96 4,488,523,260
Pluristem Therapeutics, Inc.
PSTI: NASDAQ-CM
$ 3.03 -0.03   147,056 $ 3.05
$ 2.99
$ 5
$ 2.26
NE 177,676,170
Protalix BioTherapeutics, Inc.
PLX: AMEX
$ 5.20 unch 114,075 $ 5.24
$ 5.101
$ 6.80
$ 4.71
NE 486,215,600
PDL BioPharma, Inc.
PDLI: NASDAQ-GS
$ 8.37 0.02   1,187,724 $ 8.41
$ 8.29
$ 8.475
$ 6.18
5.44 1,171,239,210
OXiGENE, Inc.
OXGN: NASDAQ-CM
$ 3.27 -0.04   10,368 $ 3.31
$ 3.2476
$ 11.7647
$ 3.101
NE 6,723,120
Osiris Therapeutics, Inc.
OSIR: NASDAQ-GM
$ 11.02 -0.05   51,085 $ 11.1799
$ 10.90
$ 14.46
$ 5.7201
NE 362,282,500
ONYX Pharmaceuticals, Inc.
ONXX: NASDAQ-GS
$ 95.23 -0.97   464,281 $ 96.07
$ 94
$ 101.569
$ 41.26
NE 6,857,131,380
Novavax, Inc.
NVAX: NASDAQ-GS
$ 2.02 -0.02   512,057 $ 2.05
$ 2
$ 2.77
$ 1.19
NE 298,840,820
NPS Pharmaceuticals, Inc.
NPSP: NASDAQ-GM
$ 14.91 -0.34   1,314,152 $ 15.22
$ 14.70
$ 16.37
$ 6.62
NE 1,295,798,280
Neurocrine Biosciences, Inc.
NBIX: NASDAQ-GS
$ 13.17 0.46   592,899 $ 13.23
$ 12.62
$ 12.85
$ 6.25
NE 875,923,530
Momenta Pharmaceuticals, Inc.
MNTA: NASDAQ-GS
$ 13.39 0.08   127,305 $ 13.50
$ 13.11
$ 17.09
$ 10.05
NE 692,878,940
Medgenics, Inc.
MDGN: AMEX
$ 4.10 -0.06   41,574 $ 4.17
$ 3.87
$ 16.43
$ 3.66
NE 75,772,100
Lpath, Inc.
LPTN: NASDAQ-CM
$ 4.99 0.05   10,819 $ 4.99
$ 4.93
$ 7.01
$ 4.13
NE 65,373,990